Clinical trials

  • LACUTAMAB for Peripheral T-cell lymphoma (relapsed/refractory) | PTCL-NOS | PTCL-TFH (including AITL, Follicular T-cell lymphoma) | Anaplastic large cell lymphoma (ALCL) | Adult T-cell leukaemia/lymphoma (ATL) | Hepatosplenic T-cell lymphoma (HSTL) | Enteropathy-associated T-cell lymphoma (EATL) | Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) | NK/T-cell lymphoma (NKT) | Aggressive NK-cell leukaemia (ANKL)
  • IOMEPROL for Breast cancer
  • ESTRADIOL HEMIHYDRATE for Gender dysphoria
  • ZOLEDRONIC ACID MONOHYDRATE for Vertebral metastases | Metastatic bone disease
  • durvalumab for Renal cell carcinoma
  • INFLIXIMAB for Axial spondyloarthritis
  • Barzolvolimab for Chronic spontaneous urticaria
  • Clinical trial in Primary ciliary dyskinesia | Chronic pulmonary Pseudomonas aeruginosa infection | Cystic fibrosis
  • Tarlatamab for Small cell lung cancer|Small cell lung cancer, extensive stage
  • EFANESOCTOCOG ALFA for Haemophilia A
  • RIKKUNSHITO for Functional dyspepsia
  • Nivolumab for Triple-negative breast cancer (metastatic)